Duke-NUS in Singapore partners with Swedish biotech startup Alder Therapeutics

Therapeutics |  News | 0 Comment | 24 Mar, 2023

In a boost to regenerative therapies for damaged hearts and eyes, Duke-NUS in Singapore has licensed two laminin-related...Read more

Australia injects $3M funding for world-first drug trial for poorly controlled epilepsy

Therapeutics |  News | 0 Comment | 22 Mar, 2023

Epilepsy affects over 150,000 Australians, and 50 million globally, with one-third struggling to control their condition...Read more

Singapore finds new way to clear brain waste linked to Alzheimer's disease

Therapeutics |  News | 0 Comment | 17 Mar, 2023

A newly discovered “energy switch” in the immune cells of the brain may lead to the development of drugs for...Read more

Australia uses smart nanotechnology for more accurate delivery of insulin

Therapeutics |  News | 0 Comment | 14 Mar, 2023

More efficient and longer lasting glucose-responsive insulin that eliminates the need for people with type 1 diabetes to...Read more

World’s first study to prove myopia prevention in children by low-concentration atropine drops

Therapeutics |  News | 0 Comment | 14 Mar, 2023

The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) conducted a randomised, placebo-con...Read more

Breakthrough neurological drug comes from New Zealand to treat Rett Syndrome

Therapeutics |  News | 0 Comment | 13 Mar, 2023

A molecule discovered by Distinguished Professor Dame Margaret Brimble of the University of Auckland, New Zealand is the...Read more

Monash University in Australia leads $15M mitochondrial donation clinical trial

Therapeutics |  News | 0 Comment | 13 Mar, 2023

Around 50 Australian children are born every year with devastating mitochondrial disease, with an expected lifespan of o...Read more

Singapore develops novel therapy for treating vancomycin-resistant bacterial infections

Therapeutics |  News | 0 Comment | 08 Mar, 2023

Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for...Read more

"We will enable researchers in Singapore to conduct homegrown large-scale population health studies"

Therapeutics |  Opinion | 0 Comment | 07 Mar, 2023

  Please share more details about the technology that has been transferred by Olink to NUS? What is so unique...Read more

Singapore accelerates precision medicine through next-generation proteomics

Therapeutics |  News | 0 Comment | 07 Mar, 2023

The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) has launched the NUS Medi...Read more

Japan discovers potential treatment of autoimmune diseases

Therapeutics |  News | 0 Comment | 07 Mar, 2023

Scientists in Japan have revealed a chemical compound that could be used for the treatment of various autoimmune disease...Read more

European Union approves first gene therapy for hemophilia B

Therapeutics |  News | 0 Comment | 23 Feb, 2023

Australian biotechnology leader CSL has announced that the European Commission has granted conditional marketing authori...Read more

Korean firms to develop novel microbiome treatment for Parkinson's disease

Therapeutics |  News | 1 Comment | 21 Feb, 2023

South Korean startup LISCure Biosciences Inc. has announced a multi-year strategic R&D collaboration with Celltrion ...Read more

New Zealand approves globally regarded soft-tissue sarcoma therapy

Therapeutics |  News | 0 Comment | 17 Feb, 2023

Singapore-headquartered biopharmaceutical company Specialised Therapeutics (ST) has announced that its portfolio therapy...Read more

Australia discovers receptor that blocks COVID-19 infection

Therapeutics |  News | 0 Comment | 14 Feb, 2023

Australia's University of Sydney scientists have discovered a protein in the lung that blocks SARS-CoV-2 infection and f...Read more

Japan develops method to design new peptide therapeutics for combating antibiotic resistance

Therapeutics |  News | 0 Comment | 13 Feb, 2023

Applications of new molecules as drugs are expected to be effective in treating diseases that are difficult to cure with...Read more

“We need to foster risky projects that can have large rewards”

Therapeutics |  Opinion | By Ayesha Siddiqui | 4 Comment | 07 Feb, 2023

What is Anticancer Bioscience’s  competitive edge and what is unique about the pipeline you are developing?&n...Read more

Singapore is beginning to see benefits of investing in technological aspect of cancer treatment

Therapeutics |  Opinion | By Chew Huat Seng, Managing Director, Hitachi Asia, Malaysia | 4 Comment | 06 Feb, 2023

Medicine and technology have made tremendous strides toward defeating one of the deadliest diseases of the world, despit...Read more